<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The aim of our study was to assess the prevalence of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and the other metabolic features in <z:mp ids='MP_0001261'>obese</z:mp> children </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We have studied 169 <z:mp ids='MP_0001261'>obese</z:mp> children and adolescents (body mass index&gt;95th percentile), 100 prepubertal and 69 pubertal, aged between 7 and 18 years </plain></SENT>
<SENT sid="2" pm="."><plain>Each subject was submitted to an oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test </plain></SENT>
<SENT sid="3" pm="."><plain>The diagnosis of <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo>, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> were defined according to modified WHO criteria adapted for children </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">Metabolic syndrome</z:e> was found in 27.2%, with a significantly higher rate among adolescents aged 12-18 years (37.6%) than among children aged 7-11 years (20%) (p &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>There were no significant differences in the prevalence of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> by sex </plain></SENT>
<SENT sid="6" pm="."><plain>The prevalences of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were 29, 19 and 2% among prepubertal children and 56.5, 27.5 and 4.3% among pubertal group, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>The prevalence of <z:hpo ids='HP_0008283'>fasting hyperinsulinemia</z:hpo> in pubertal group was significantly higher than prepubertal children (p &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000842'>Hyperinsulinemia</z:hpo> was also more frequent in pubertal children with significant difference (20% versus 43.7%, p &lt; 0.001) </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000822'>Hypertension</z:hpo> was significantly more common in adolescents (31.8%) than children (15%) with <z:hpo ids='HP_0001513'>obesity</z:hpo>, as expected (p &lt; 0.013) </plain></SENT>
<SENT sid="10" pm="."><plain>Overall, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e> in prepubertal and pubertal groups was identified in 42 and 55%, respectively, with no significant differences (p = 0.085) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> prevalences among adolescents are quite high in the urban area of Konya, central Anatolia, with abnormal <z:chebi fb="23" ids="18059">lipid</z:chebi> profiles, <z:hpo ids='HP_0001513'>obesity</z:hpo> and nutritional mistakes </plain></SENT>
</text></document>